Evidence map›Paper›PMID 28596951›Full record

ReviewFrontiers in pediatrics2017

Early-Life Host-Microbiome Interphase: The Key Frontier for Immune Development.

Nelly Amenyogbe, Tobias R Kollmann, Rym Ben-Othman

Abstract readReview
In one paragraph

Review in Frontiers in pediatrics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Impact ofVaccines · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Observational
  11. Article
  12. Review
  13. Article
  14. Article
  15. The Impact ofCells · 2022
    Article
  16. Article
  17. Article
  18. Supplementation withBMJ open · 2021
    Article
  19. The Gut-Lung Axis in Cystic Fibrosis.Journal of bacteriology · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Nelly AmenyogbeDepartment of Experimental Medicine, University of British Columbia, Vancouver, BC, Canada.
Tobias R KollmannDepartment of Pediatrics, University of British Columbia, Vancouver, BC, Canada.
Rym Ben-OthmanDepartment of Pediatrics, University of British Columbia, Vancouver, BC, Canada.

Funding

Transcriptomics to define biomarkers of neonatal vaccine immunogenicityU19AI118608 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI LEVY, OFER · 2017 to 2021
$24.7M
NIAID NIH HHS U19 AI118608
6 · The paper itself

Abstract

Human existence can be viewed as an "

Indexed as

immune diseasesimmunity and infectionsmicrobiomeontogenyprobiotics

Identifiers

PMID28596951
PMCPMC5442244

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.